{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:42:18Z","timestamp":1775806938313,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Korea Medical Device Development Fund grant funded by the Korea government","award":["202013B14"],"award-info":[{"award-number":["202013B14"]}]},{"name":"the Korea National Research Foundation funded by the Ministry of Education, Science and Technology","award":["2020R1F1A106740"],"award-info":[{"award-number":["2020R1F1A106740"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00392-021-01899-8","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T10:02:47Z","timestamp":1625306567000},"page":"284-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hypertension control and end-stage renal disease in atrial fibrillation: a nationwide population-based cohort study"],"prefix":"10.1007","volume":"111","author":[{"given":"Soonil","family":"Kwon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So-Ryoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0411-6372","authenticated-orcid":false,"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hyung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seil","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,3]]},"reference":[{"issue":"4","key":"1899_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ahj.2009.06.031","volume":"158","author":"H Watanabe","year":"2009","unstructured":"Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y (2009) Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 158(4):629\u2013636","journal-title":"Am Heart J"},{"issue":"5","key":"1899_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.112.123992","volume":"127","author":"N Bansal","year":"2013","unstructured":"Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS (2013) Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation 127(5):569\u2013574","journal-title":"Circulation"},{"key":"1899_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ijcard.2015.03.104","volume":"185","author":"WT O'Neal","year":"2015","unstructured":"O\u2019Neal WT, Tanner RM, Efird JT, Baber U, Alonso A, Howard VJ et al (2015) Atrial fibrillation and incident end-stage renal disease: the reasons for geographic and racial differences in stroke (REGARDS) study. Int J Cardiol 185:219\u2013223","journal-title":"Int J Cardiol"},{"issue":"7","key":"1899_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1105594","volume":"367","author":"JB Olesen","year":"2012","unstructured":"Olesen JB, Lip GYH, Kamper AL, Hommel K, Kober L, Lane DA et al (2012) Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 367(7):625\u2013635","journal-title":"N Engl J Med"},{"issue":"23","key":"1899_CR5","first-page":"e199","volume":"130","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr et al (2014) 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 130(23):e199-267","journal-title":"Circulation"},{"issue":"5","key":"1899_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2020","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C et al (2020) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373\u2013498","journal-title":"Eur Heart J"},{"issue":"4","key":"1899_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/europace\/eun369","volume":"11","author":"M Nabauer","year":"2009","unstructured":"Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P et al (2009) The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace 11(4):423\u2013434","journal-title":"Europace"},{"key":"1899_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019209","author":"RH Cha","year":"2020","unstructured":"Cha RH, Lee H, Lee JP, Kim YS, Kim SG (2020) The influence of blood pressure patterns on renal outcomes in patients with chronic kidney disease: the long-term follow up result of the APrODiTe-2 study. Medicine. https:\/\/doi.org\/10.1097\/MD.0000000000019209","journal-title":"Medicine"},{"issue":"9","key":"1899_CR9","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4070\/kcj.2020.0171","volume":"50","author":"EK Choi","year":"2020","unstructured":"Choi EK (2020) Cardiovascular research Using the Korean national health information database. Korean Circ J 50(9):754\u2013772","journal-title":"Korean Circ J"},{"issue":"5","key":"1899_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311(5):507\u2013520","journal-title":"JAMA"},{"issue":"8","key":"1899_CR11","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jacc.2018.05.066","volume":"72","author":"SR Lee","year":"2018","unstructured":"Lee SR, Choi EK, Han KD, Jung JH, Oh S, Lip GYH (2018) Edoxaban in Asian patients with atrial fibrillation: effectiveness and safety. J Am Coll Cardiol 72(8):838\u2013853","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1899_CR12","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jacc.2018.11.051","volume":"73","author":"SR Lee","year":"2019","unstructured":"Lee SR, Choi EK, Park CS, Han KD, Jung JH, Oh S et al (2019) Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and low body weight. J Am Coll Cardiol 73(8):919\u2013931","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1899_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","volume":"14","author":"GYH Lip","year":"2017","unstructured":"Lip GYH (2017) The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol 14(11):627\u2013628","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"1899_CR14","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.jacc.2018.05.076","volume":"72","author":"D Kim","year":"2018","unstructured":"Kim D, Yang PS, Kim TH, Jang E, Shin H, Kim HY et al (2018) Ideal blood pressure in patients with atrial fibrillation. J Am Coll Cardiol 72(11):1233\u20131245","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"1899_CR15","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JRJC et al (2014) 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64(21):e1-76","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1899_CR16","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D et al (2020) 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 75(6):1334\u20131357","journal-title":"Hypertension"},{"issue":"6","key":"1899_CR17","first-page":"e13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Himmelfarb CD et al (2018) 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71(6):e13\u2013e115","journal-title":"Hypertension"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01899-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-021-01899-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01899-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T18:05:59Z","timestamp":1645725959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-021-01899-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1899"],"URL":"https:\/\/doi.org\/10.1007\/s00392-021-01899-8","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,3]]},"assertion":[{"value":"31 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SK, SRL, JHJ, KDH, SO: none to disclose. EKC: research grants from Bayer, BMS\/Pfizer, Biosense Webster, Chong Kun Dang, Daiichi-Sankyo, Samjinpharm, Sanofi-Aventis, Seers Technology, Skylabs, and Yuhan. No fees are received personally. GYHL: consultant for Bayer\/Janssen, BMS\/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon and Daiichi-Sankyo. Speaker for Bayer, BMS\/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo. No fees are received personally.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Institutional Review Board of Seoul National University Hospital approved the study (No. 2008\u2013048-1147) and adhered to the Declaration of Helsinki. Informed consent was exempted because the study used anonymous data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval consent to participate"}}]}}